The aim of this thesis is tovalidate the
effect of iron and erythropoietin treatment on theHbA1c of
hemodialysis patients with diabetes.
Methods:This study was conducted on 50 HD patients
withtype-2 diabetes.All patients were selected from those under
going regular HD in nephrology and dialysis unit inBanha
University Hospitals. .the diagnosis of diabetes was based on a
history of diabetes or on the ADA criteria. The patients
classified into two groups (each consists of 25 patients).The
first group (group A) are patients selected for iron therapy
according to clinical need.The second group (group B)
consisted of patients required ESA treatment.Glycemic control
in both patient groups were assessed using HbA1c in the month
leading up to treatment and once again for a 4-week period 4
months after therapy.
Results:A1C value falls after four months of therapy inboth
groups(iron and ESA group) compared to before therapy .this
change was independent on glycemic control.
Conclusions: This study showed that iron and ESA treatments
resulted a significant fall in A1C, which was independent on
glycemic changes in patients with diabetes and CKD.